Exhibit 99.1 AGREEMENT TO JOINTLY FILE SCHEDULE 13D The undersigned hereby agree to jointly prepare and file with regulatory authorities a Schedule 13D and any future amendments thereto reporting each of the undersigned's ownership of securities of...Joint Filing Agreement • July 10th, 2006 • Rosenwald Lindsay a Md • Biological products, (no disgnostic substances)
The undersigned hereby agree to jointly prepare and file with regulatory authorities a Schedule 13D and any future amendments thereto reporting each of the undersigned's ownership of securities of Innovive Pharmaceuticals and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned.
AGREEMENT TO JOINTLY FILE SCHEDULE 13DJoint Filing Agreement • February 13th, 2008 • Rosenwald Lindsay a Md • Biological products, (no disgnostic substances)
The undersigned hereby agree to jointly prepare and file with regulatory authorities a Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of Innovive Pharmaceuticals, Inc. and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned.
AGREEMENT TO JOINTLY FILE SCHEDULE 13GJoint Filing Agreement • February 3rd, 2009 • Rosenwald Lindsay a Md • Pharmaceutical preparations
AGREEMENT TO JOINTLY FILE SCHEDULE 13DJoint Filing Agreement • February 3rd, 2009 • Rosenwald Lindsay a Md • Pharmaceutical preparations
RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • January 28th, 2016 • Rosenwald Lindsay a Md • Pharmaceutical preparations • Delaware
This RESTRICTED STOCK AWARD AGREEMENT (the “Agreement”) is made and entered into effective as of __________, _____, by and between Fortress Biotech, Inc., a Delaware corporation (the “Company”), and __________ (the “Grantee”).
AGREEMENT TO JOINTLY FILE SCHEDULE 13DJoint Filing Agreement • February 13th, 2008 • Rosenwald Lindsay a Md • Pharmaceutical preparations
The undersigned hereby agree to jointly prepare and file with regulatory authorities a Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of Cougar Biotechnology, Inc. and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned.
